Acquisition offers 300 new employees and a bigger product portfolio.
Acino, a Swiss pharmaceutical company, revealed that it has entered into an agreement to acquire M8 Pharmaceuticals, a biopharma organization headquartered in Mexico City. Focusing on licensing, marketing, and distributing medicines in Mexico and Brazil, the acquisition supplements Acino’s current Latin American presence, with operations in eight other countries throughout the region.
“This is a transformative deal for Acino, significantly expanding our presence in Latin America and delivering against our overall strategy and stated intention to increase patient’s access to high-quality pharmaceuticals and diversify our footprint in key high-growth markets,” said Andrew Bird, interim CEO, Acino, in a company press release. “We see M8 and Acino as highly complementary offerings, and we are confident that we can use this acquisition as a catalyst to further increase value and accelerate growth for Acino in this key region.”
Reference: Acino significantly expands presence and capabilities in Latin America through acquisition of M8 Pharmaceuticals. Globe Newswire. September 20, 2023. Accessed September 20, 2023. https://www.globenewswire.com/news-release/2023/09/20/2746398/0/en/Acino-significantly-expands-presence-and-capabilities-in-Latin-America-through-acquisition-of-M8-Pharmaceuticals.html
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
Trends in Continuing Medical Education
April 12th 2024Elliott Yoo, Senior Media Strategist at epocrates, takes a closer look at the trends in CME consumption and what the future of medical education will be – from the priorities for physicians as they juggle learning with patient care, to what type of activities resonate most with prescribers.
Beyond the Scrubs: Understanding Healthcare Providers as People for Increased Engagement
March 28th 2024The benefits of adopting a humanized approach to healthcare provider marketing extend across the healthcare spectrum, enhancing engagement rates, brand loyalty, and marketing ROI, while also driving better outcomes for patients.